StockData
Gossamer Bio, Inc. logo

Gossamer Bio, Inc. (GOSS) stock

GOSSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 1/30
$11.04+0.06 (+0.55%)

Close on Nov 17, 2026Market cap $5.40BP/E –Yield –

Gossamer Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Gossamer Bio's price to book ratio was 7.8× on Apr 30, 2025, against 2.5× a year earlier. Over the last 5 years it ranged from 1.4× to 28.5×, with a median of 2.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 20257.8×+4.1
2024Dec 31, 20243.8×+1.8
2023Dec 29, 20232.0×−1.7
2022Dec 30, 20223.6×−1.4
2021Dec 31, 20215.0×+3.1
2020Dec 31, 20201.9×−0.5
2019Dec 31, 20192.4×–

More Gossamer Bio figures

See a number that looks wrong?